secwatch.observer — SEC 8-K summary
======================================

Issuer:     DiaMedica Therapeutics Inc. (DMAC)
CIK:        0001401040
Form:       8-K
Filed at:   2025-08-12T23:59:59+00:00
Accession:  0001437749-25-026286
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DiaMedica enters $100M ATM equity distribution agreement with TD Cowen
----------------------------------------------------------------------

- Up to $100M in common shares may be sold through TD Cowen as sales agent.
- TD Cowen earns up to 3.0% commission on gross proceeds from ATM sales.
- Sales cannot occur until the related Form S-3 shelf registration is declared effective.
- Proceeds use not specified; agreement includes customary indemnification provisions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401040/000143774925026286/0001437749-25-026286-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401040/000143774925026286/dmtp20250812_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-026286

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer